I now have comprehensive information from multiple authoritative textbooks. Here is the complete treatment guide:
Migraine - Full Treatment Guide
Figure: Migraine attack phases and treatment agents - Lippincott Illustrated Reviews Pharmacology
Part 1 - Acute (Abortive) Treatment
The key principle: treat early - at the onset of aura or the very first sign of headache. Waiting too long reduces drug effectiveness significantly.
Step 1 - Mild to Moderate Attacks (First Line)
NSAIDs / Simple Analgesics
- Aspirin, ibuprofen, naproxen, or acetaminophen
- Try 2-3 different NSAIDs across separate attacks to find the best one
- Use moderately high doses if needed
- Warning: Overuse (>10-15 days/month) causes medication overuse headache (MOH/rebound headache) - a cycle of relief then worsening
Combination Products
- Sumatriptan + naproxen (available as a fixed-dose oral combination)
- Aspirin + acetaminophen + caffeine (OTC combination)
Step 2 - Moderate to Severe Attacks (Disease-Specific)
A. Triptans (First-Line Specific Therapy)
Mechanism: 5-HT1B/1D receptor agonists - cause vasoconstriction and inhibit proinflammatory neuropeptide release from the trigeminal system. Abort attacks in ~70% of patients.
| Drug | Route | Dose | Notes |
|---|
| Sumatriptan | SC | 6 mg | Fastest onset (~20 min); prototype triptan |
| Sumatriptan | Oral | 25, 50, 100 mg | Onset 1-2 hours |
| Sumatriptan | Nasal | 20 mg | Intermediate onset |
| Zolmitriptan | Oral/Nasal | 2.5 mg or 5 mg | |
| Rizatriptan | Oral | 5 or 10 mg; repeat in 2h if needed | |
| Frovatriptan | Oral | - | Longest half-life (>24h); good for menstrual migraine |
| Almotriptan, Eletriptan, Naratriptan | Oral | Various | If one fails, try another |
Important notes on triptans:
- Give SC/nasal during aura; give oral during aura or at headache onset
- If one triptan fails, try a different one or a different route
- Headache recurrence within 24-48 hours is common; a second dose is usually effective
- Contraindicated in: ischemic heart disease, uncontrolled hypertension, basilar/hemiplegic migraine, cerebrovascular disease
- Side effects: chest/neck/jaw pressure, dizziness, malaise
B. Ergot Alkaloids
| Drug | Route | Dose | Notes |
|---|
| Ergotamine tartrate | Sublingual / oral | 1-2 mg | Take with caffeine; limit use (causes rebound); also has dopamine and alpha-receptor activity |
| Dihydroergotamine (DHE) | IV / Intranasal | 1 mg IV over 3 min | Severe/refractory migraine; pretreat with antiemetic; efficacy similar to sumatriptan |
- Contraindicated in: pregnancy (Cat X), coronary artery disease, peripheral vascular disease, uncontrolled hypertension, within 24h of triptan use
- Main side effects: nausea, vomiting, vasoconstriction
C. Newer Agents (When Triptans/Ergots are Contraindicated or Failed)
Ditans:
- Lasmiditan (oral) - selective 5-HT1F agonist; does NOT cause vasoconstriction, safe in cardiovascular disease; classified as a controlled substance; causes driving impairment
CGRP Receptor Antagonists (Gepants):
- Ubrogepant (oral) - acute migraine; avoid with strong CYP3A4 inhibitors
- Rimegepant (oral) - can be used for both acute AND prevention
- CGRP levels are elevated during acute migraine attacks
- Side effects: nausea, somnolence (low incidence)
Step 3 - Antiemetics (Adjunct Treatment)
Used to treat nausea/vomiting and have independent analgesic effects in migraine:
| Drug | Dose | Notes |
|---|
| Prochlorperazine | 5-10 mg IV/PR | Give diphenhydramine concurrently to prevent dystonia |
| Metoclopramide | 10 mg IV | Give diphenhydramine concurrently |
| Promethazine | 50 mg oral | Given with ergotamine to reduce nausea |
| Chlorpromazine | 7.5 mg IV | Pre-treat with saline to prevent hypotension |
| Droperidol | 2.5 mg IV/IM | Can prolong QT interval |
Step 4 - Emergency / Refractory Migraine
| Drug | Dose | Notes |
|---|
| Ketorolac | 10-30 mg IV/IM | Good parenteral NSAID option |
| Magnesium sulfate | 2g IV over 30 min | Especially in migraine with aura; also effective in preeclampsia |
| Dexamethasone | 6-10 mg IV | Adjunctive; reduces headache recurrence |
| Methylprednisolone | 125 mg IV/IM | Rescue therapy |
| IV Aspirin (lysine acetylsalicylate) | 1g IV, repeat up to 5x | Used in inpatient setting |
| Valproate sodium | 500 mg IV | Not validated; avoid in pregnancy (Cat X) |
| Ketamine | 0.1-0.3 mg/kg IV | Does not raise ICP; option in head trauma patients |
Part 2 - Preventive (Prophylactic) Treatment
When to start prevention: Attacks occurring 2+ times per month, OR severe/disabling attacks, OR neurologic complications.
First-Line Preventives
| Drug Class | Drug | Dose | Choose when... |
|---|
| Beta-blockers | Propranolol | 10-20 mg TDS, titrate up to 240 mg/day | Hypertension, anxiety; severity is main concern |
| Metoprolol | 100-200 mg/day | |
| Atenolol | 40-160 mg/day | |
| Timolol | 20-40 mg/day | |
| Tricyclic antidepressants | Amitriptyline | 25-125 mg at night | Comorbid depression, very frequent headaches |
| Anticonvulsants | Topiramate | Standard doses | Comorbid epilepsy; also aids weight loss |
| Valproic acid | 250 mg TDS-QID | Avoid in women of childbearing age (teratogenic) |
Note: SSRIs are generally NOT effective for migraine prevention and may even worsen headaches.
Second-Line Preventives
| Drug | Dose | Notes |
|---|
| Verapamil | 320-480 mg/day | Calcium channel blocker; lag of days-weeks before benefit |
| Nifedipine | 90-360 mg/day | |
| Venlafaxine | Standard dose | SNRI antidepressant |
| Indomethacin | 150-200 mg/day | Particularly useful for perimenstrual migraine |
| Cyproheptadine | 4-16 mg nightly | Useful in children and perimenstrual migraine |
Newer/Advanced Preventives
Anti-CGRP Monoclonal Antibodies (given monthly or quarterly by injection):
- Erenumab - targets the CGRP receptor
- Galcanezumab - targets CGRP ligand
- Fremanezumab - targets CGRP ligand
- Eptinezumab - IV infusion quarterly
These are indicated in patients who fail conventional preventives, or in chronic migraine.
Oral CGRP Antagonists (dual use - acute + prevention):
- Rimegepant and Atogepant - can be used for prevention
OnabotulinumtoxinA (Botox):
- Injected into temporalis and other cranial muscles
- Provides headache relief for 2-4 months per treatment cycle
- Used in chronic migraine (>15 headache days/month)
Part 3 - Non-Pharmacological Measures
- Trigger avoidance: Chocolate, red wine, smoked/processed meats, peanuts, oranges, aged cheese, caffeine (excessive)
- Regular sleep schedule - both sleep deprivation and oversleeping trigger attacks
- Stress management - structured lifestyle changes, avoiding hard-driving patterns
- Biofeedback and relaxation therapy - supported by trials though results vary
- Acupuncture - has advocates; evidence modest
- Refractive error correction - if applicable
- Caffeine: Limiting helps prevent rebound; small amounts during attack may help
- Menstrual migraine: Frovatriptan (long half-life) or indomethacin taken perimenstrually can be preventive
Quick Reference Summary
MILD ATTACK → NSAIDs / Acetaminophen
MODERATE-SEVERE → Triptans (oral/nasal) ± antiemetic
SEVERE/EARLY → Sumatriptan SC, or DHE IV + antiemetic
NO TRIPTAN/CVD → Lasmiditan or Gepants (ubrogepant, rimegepant)
EMERGENCY DEPT → Ketorolac IV + prochlorperazine IV + dexamethasone IV
PREVENTION (1st) → Beta-blocker OR amitriptyline OR topiramate/valproate
PREVENTION (2nd) → Calcium channel blockers, CGRP antibodies, Botox
Sources: Adams and Victor's Principles of Neurology, 12th Ed. | Lippincott Illustrated Reviews: Pharmacology | Tintinalli's Emergency Medicine | Goodman & Gilman's Pharmacological Basis of Therapeutics
Recent evidence (2025): A
new evidence-based guideline published in
Cephalalgia (April 2025, PMID 40277319) provides updated pharmacological treatment recommendations - consistent with the above framework but may include updated rankings for gepants and CGRP antibodies as first-line options in certain patient populations.